Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 9/20 | 1.00 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.57 |
| ▸ | F2 | P00734 | 2/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | PLAT | P00750 | 1/20 | 0.50 |
| ▸ | KLK1 | P06870 | 1/20 | 0.50 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31339193 | 1.00 | PLAU (1.00) | PLAUPRSS1F2PLGPLAT | |
| Hydrochloric Acid SCHEMBL7336518 | 0.99 | PLAU (0.97) | PLAUPRSS1F2PLGPLAT | |
| Hydrochloric Acid SCHEMBL7372291 | 0.83 | PLAU (0.71) | PLAUPRSS1F2PLGPLAT | |
| SCHEMBL7369251 | 0.83 | PLAU (0.71) | PLAUPRSS1F2PLGPLAT | |
| Hydrochloric Acid SCHEMBL7335552 | 0.82 | PLAU (0.69) | PLAUPRSS1F2PLGPLAT | |
| SCHEMBL7334984 | 0.79 | PLAU (0.65) | PLAUPRSS1F2PLGPLAT | |
| SCHEMBL7855500 | 0.75 | PLAU (0.60) | PLAU | |
| SCHEMBL7855504 | 0.75 | PLAU (0.60) | PLAU | |
| Hydrochloric Acid SCHEMBL7343861 | 0.74 | PLAU (0.59) | PLAU | |
| Hydrochloric Acid SCHEMBL7336522 | 0.74 | PLAU (0.59) | PLAUPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010049374-A1 | Urokinase inhibitors | STEELE ANDREW W (US) | 2001-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010049374-A1 | Urokinase inhibitors | SERPINE1, PLAU, SERPINB1 | PLAU 2/4885PRSS1 16/4885F2 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.